Effects of sacubitril/valsartan on B-type natriuretic peptide circulating levels and loop diuretic dose in a case series of stabilized heart failure patients with left ventricular ejection fraction ≤35%-Reference-Cited by-同舟云学术

Effects of sacubitril/valsartan on B-type natriuretic peptide circulating levels and loop diuretic dose in a case series of stabilized heart failure patients with left ventricular ejection fraction ≤35%

Published:2019-03-21 Issue:sup3 Volume:35 Page:13-18
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Pugliese Nicola Riccardo¹²,Fabiani Iacopo²³,Zywicki Viola²,Mazzola Matteo²,D’Agostino Andreina²,Galeotti Gian Giacomo²,Dini Frank Lloyd²

Affiliation:

1. Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy;

2. Cardiac, Thoracic and Vascular Department, University of Pisa, Pisa, Italy;

3. Department of Surgical, Medical, Molecular and Critical Area Pathology, University of Pisa, Pisa, Italy

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2019.1598702

Reference13 articles.

1. Natriuretic Peptides in Heart Failure

2. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

3. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

4. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure

5. Monitoring B-type natriuretic peptide in patients undergoing therapy with neprilysin inhibitors. An emerging challenge?

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress in Managing Heart Failure: an in-depth Review of Sacubitril/Valsartan Combination Therapy;MGM Journal of Medical Sciences;2024-04

2. Effect of sacubitril/valsartan on brain natriuretic peptide level and prognosis of acute cerebral infarction;PLOS ONE;2023-09-21

3. Sacubitril/Valsartan Does Not Change the Use and Dose of Loop Diuretics in Patients With Heart Failure With Reduced Ejection Fraction;Journal of Pharmacy Practice;2023-05-16

4. Haemodynamic Effects of Sacubitril/Valsartan Initiation in Outpatients with Chronic Heart Failure;American Journal of Cardiovascular Drugs;2022-09-22

5. B-Type Natriuretic Peptide (BNP) Revisited—Is BNP Still a Biomarker for Heart Failure in the Angiotensin Receptor/Neprilysin Inhibitor Era?;Biology;2022-07-09